Hers vs CoreAgeRx: Brand-name GLP-1s vs Flat Pricing Options
Hers vs CoreAgeRx compares a brand-name, FDA‑approved focused offering against a flat‑price, no‑membership model. Early verdict: choose Hers if you prioritize FDA‑approved Wegovy® and a personalized care team; choose CoreAgeRx if you prefer flat monthly pricing and no membership fee.
Key differences at a glance
| Criteria | Hers | CoreAgeRx |
|---|---|---|
| Pricing headline | Wegovy® pill from $149/mo · injectable from $199/mo | Flat monthly pricing: $129/Month (tirzepatide) · $79/Month (semaglutide) |
| Membership required | Active Hers Weight Loss Membership required; $39 first month, auto‑renews at $149/month thereafter (medication billed separately) | No membership fee; “No memberships” and “Same Price. Every Month.” |
| Medication types and approval | Offers FDA‑approved Wegovy® (brand‑name semaglutide); no compounded medications | Offers semaglutide and tirzepatide dosing options; medication approval status must be confirmed |
| Care and visit model | Personalized care team with ongoing dose check‑ins | 3‑minute online visit; emphasizes consistent same monthly bill |
| Price stability | Lists starting prices; membership and billing separate, not guaranteed | Promotes “No price hike, no membership fee, no billing surprises” and “Same price every month” |
1. Pricing structure and membership
Hers lists “Wegovy® pill from $149/mo · injectable from $199/mo” and states that an active Hers Weight Loss Membership is required (“$39 for the first month, auto‑renews at $149/month thereafter”). Total cost includes the membership fee and, if prescribed, medication; membership and medication are billed separately and a prescription is not guaranteed. CoreAgeRx emphasizes “Same Price. Every Month.” and “No membership fee.” CoreAgeRx lists $129/Month for tirzepatide and $79/Month for semaglutide and markets “No price hike, no membership fee, no billing surprises.”
2. Medication types, FDA status, and compounding
Hers explicitly offers FDA‑approved Wegovy® (brand‑name semaglutide) and states it does not offer compounded medications. The source preserves regulatory notes that compounded medications are not FDA‑approved. CoreAgeRx lists semaglutide and tirzepatide dosing options (semaglutide up to 1.0 mg; tirzepatide up to 7.5 mg) and notes that medication‑specific approval status must be confirmed; captured material says “Medication-specific approval status must be confirmed; branded and compounded products are not interchangeable.” Use only the supplied facts when weighing FDA‑approved brand‑name availability against CoreAgeRx pricing claims.
3. Care model and ongoing support
Hers markets a “personalized care team with ongoing dose check‑ins,” which indicates ongoing clinician involvement as part of the program. CoreAgeRx promotes a fast “3‑MINUTE ONLINE VISIT” and emphasizes consistent monthly billing; the landing page highlights that GLP‑1 treatment takes consistency and that CoreAgeRx seeks to avoid surprise price increases over time. The sources do not supply identical details about clinician qualifications or protocol; they state that treatment is available only when a licensed clinician determines it is medically appropriate.
4. Dosing options and limits
Hers lists semaglutide and mentions “High dose available” and includes tirzepatide pricing lines in captured content, though exact dose limits are not specified beyond advertised product types. CoreAgeRx specifically lists semaglutide “any dose up to 1.0 mg” and tirzepatide “any dose up to 7.5 mg” on its landing page. The comparison sources preserve that dose availability and any clinical eligibility are subject to clinician review.
Quick comparison table summary
| Feature | Hers | CoreAgeRx |
|---|---|---|
| Starting price shown | From $149/mo (Wegovy® pill) | $129/Month (tirzepatide) · $79/Month (semaglutide) |
| Membership | Required; fee applies and auto‑renews | No membership fee |
| FDA brand availability | Offers FDA‑approved Wegovy®; not compounded | Lists drugs and doses; approval status must be confirmed |
| Care model | Personalized care team with ongoing dose check‑ins | 3‑minute online visit; emphasizes price stability |
| Price stability claim | Starting prices listed; membership and medication billed separately | “Same Price. Every Month.” and “No price hike” |
What is not supplied
The sources do not provide verifiable details about outcomes, long term efficacy, shipping speed for each provider, or a complete FAQ comparison. Any medication prescription, dose, coverage, eligibility and state availability are subject to clinician review, and the sources caution that medication may not be available without meeting eligibility criteria.
Final verdict: Hers vs CoreAgeRx
Hers centers on providing FDA‑approved Wegovy® and emphasizes a personalized care team and that it does not offer compounded medications, with starting pricing shown at “From $149/mo” and a membership requirement. CoreAgeRx centers on flat monthly pricing, “No membership fee,” and specific listed monthly prices ($129 and $79) and dose caps on its landing page. Choose based on whether you prioritize FDA‑approved brand medications plus ongoing dose check‑ins or a no‑membership, price‑stable monthly plan.
Choose Hers if…
- You want an FDA‑approved brand‑name option like Wegovy® and a program that states it does not use compounded medications.
- You value a personalized care team with ongoing dose check‑ins and accept a membership requirement and separate medication billing.
Choose CoreAgeRx if…
- You want flat monthly pricing with “No membership fee” and the advertised same price every month for semaglutide or tirzepatide.
- You prefer a program that emphasizes a quick online visit and predictable recurring charges as presented on its landing page.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
